ArticleBiomedicines2025
Evolving Management Paradigms in Dural Arteriovenous Fistulas: From Classification to Personalized Endovascular Therapy.
Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Progressive intracranial venous reflux with cognitive decline in a hemodialysis patient: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dural arteriovenous fistulas (dAVFs) represent a unique subset of intracranial vascular malformations characterized by pathologic shunting between dural arteries and venous sinuses or cortical veins. Although once considered rare and uniformly high-risk, modern imaging and therapeutic innovations have revealed a spectrum of biological behavior ranging from benign to aggressive. The past decade has witnessed a paradigm shift from purely anatomic classification toward individualized, hemodynamic-based decision-making that incorporates endovascular, microsurgical, and radiosurgical techniques. This Perspective reviews the evolving management of dAVFs, emphasizing early recognition of cortical venous drainage, endovascular innovation, venous sinus reconstruction, and the emerging role of artificial intelligence and personalized medicine in risk stratification. Accordingly, we seek to delineate how a precision approach based on angioarchitecture, patterns of venous flow, and clinical phenotype has transformed the treatment of dAVFs from a purely reactive to a potentially curative discipline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.